Reproductive Health Innovation Summit 2023

Reproductive Health Innovation Summit

Connecting industry leaders to spark innovation, investment, access, and solutions across the reproductive health spectrum

Download the 2023 Agenda
Boston, USA
15-16 February, 2023

“As always, I am excited to engage with this community of inspiring women’s health innovators and learn about the new solutions bridging the healthcare gap for women globally.”

Erica Kantor, Head of Women’s Health, Sagentia Innovation

WHY ATTEND

The Reproductive Health sector is due to have an estimated global value of $171 billion by 2027, propelling it as a market leading category in the women’s health industry.

Essential, disruptive solutions are emerging from the driving forces of start-ups, Femtech, and technology innovators, all with the overarching aim of aiding unmet needs within reproductive health journeys.

The 3rd annual Reproductive Health Innovation Summit (15th -16th February 2023) is the destination for sourcing and accelerating opportunity in fertility, contraception, and maternal health, from AI and big data to non-hormonal devices and solutions, new care delivery models and consumer wearables.

Join us in 2023 to:

  • Tackle the challenges straddling the reproductive health sector, including funding, insurance coverage, access, and ongoing stigmas.
  • Dive deeper into our 3 leading innovation topics: contraception, fertility, and maternal health, to gain insights into the latest research, innovations, challenges, and opportunities, for bringing better care and access to both men and women.  
  • Network with 350+ industry leaders and changemakers within our numerous 1-2-1 opportunities, interactive roundtables, and breakout sessions throughout the 2 days.

Advisory Board

Author:

Alice Zheng

Principal
RH Capital

Alice Zheng

Principal
RH Capital

Author:

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Author:

Elizabeth Garner

Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

Chief Scientific Officer, US
Ferring Pharmaceuticals

Author:

Kalahn Taylor-Clark, PhD, MPH

Vice President Strategic Partnerships and Innovation
Myovant Sciences

Kalahn Taylor-Clark, PhD, MPH

Vice President Strategic Partnerships and Innovation
Myovant Sciences

Author:

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health
The National Institute of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health
The National Institute of Health (NIH)

Author:

Raymon uit de Bulten

Director Start-Up Venturing Leader
Philips

Raymon uit de Bulten

Director Start-Up Venturing Leader
Philips

Author:

Lucy Perez, PhD

Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez, PhD

Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Author:

Sandy Milligan

MD, JD, Head of R&D
Organon

Sandy Milligan

MD, JD, Head of R&D
Organon

Testimonials & Success Stories

2023 Innovation Showcase

2023 Selection Committee

Showcasing the most innovative and disruptive companies in reproductive health.

- An opportunity for 12 start-up finalists from the reproductive health sphere to present - their innovation in front of our audience of 300+ attendees.
- An expanded Selection Committee of leading investors who will provide their expertise and feedback in person.
- An all-new prize bundle including personalised, top-level prizes to set your business up for scale.

2023 Prize Bundle includes:


- VIP Pass + Guest to a future WHIS event of your choice

- Showcase Finalist Breakfast on Day 2
- 1-2-1 Coaching with FemTech Lab
- 1- Hour 1-2-1 Consultation Session with Fempower Health
- 1-hour personalized Capital Raise Strategy with She Raises Capital 

Applications Close 23rd of December

       APPLY HERE FOR THE INNOVATION SHOWCASE

CEO & FOUNDERS FORUM

Come together with like-minded leaders in women’s health to learn, networgrow. The CEO & Founders Forum is an application-only event and we will inform you if you are accepted to join.

FORUM ONLY APPLICATION

INVESTOR FORUM

The Investor Forum will offer further networking and discussion for investors in the women’s health space who share the same passion for driving change and accelerating innovation.

Register your interest in the forum and a team member will be in touch with further information.

REGISTER INTEREST

Poster Presentation

Here at the Reproductive Health Innovation Summit, we truly value the attendance of academics and researchers working in this space. Ground-breaking research, development of solutions, and the acceleration of innovation are of paramount importance when driving change in the broader women’s health sector.

 

This exclusive poster session will give you the opportunity to showcase your research, discovery, or story in front of over 300 reproductive health industry leaders including start-ups, large pharmaceutical companies, and investors.

 

Register now and secure yourself 1 of 20 exclusive poster spots at #RHIS2023!

APPLY HERE FOR THE POSTER PRESENTATION

2023 Speakers

 

Alice Zheng, MD, MBA, MPH

Principal
RH Capital

Alice Zheng, MD, MBA, MPH

Principal
RH Capital

Alice Zheng, MD, MBA, MPH

Principal
RH Capital
 

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic
 

Elizabeth Garner

Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

Chief Scientific Officer, US
Ferring Pharmaceuticals
 

Barbara Collura

President CEO
RESOLVE

Barbara Collura

President CEO
RESOLVE

Barbara Collura

President CEO
RESOLVE
 

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth
 

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds
 

Marsha Henderson

Former Associate Commissioner Women's Health
FDA

Marsha Henderson

Former Associate Commissioner Women's Health
FDA

Marsha Henderson

Former Associate Commissioner Women's Health
FDA
 

David Stern

CEO
Boston IVF

David Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.

 

David Stern

CEO
Boston IVF

David Stern

CEO
Boston IVF

David Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.

 

David served as CEO of Symbiomix Therapeutics a venture backed biotech company. He led the transition of the company from development stage to commercial launch in the US, prior to its acquisition by Lupin Pharmaceuticals in 2017. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy and expanding scientific partnerships for Celmatix, Ohana and OvaScience.

 

David was the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. Prior to his global role, he was responsible for the US commercial operations in the Fertility, HIV and Growth Hormone markets. David started his career in women’s health with Organon Pharmaceutics. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.

 

Casey Santiago

Managing Partner
Steelsky Ventures

Casey Albert Santiago has 20 years of global operating experience building, scaling and investing in women’s health companies. Casey is a Managing Partner at SteelSky Ventures, a female-led venture capital fund investing in early-stage companies that improve access, care, and outcomes in women's health. Prior to joining SteelSky, Casey invested in early-stage digital health & consumer health start-ups in partnership with Johnson & Johnson.

Casey Santiago

Managing Partner
Steelsky Ventures

Casey Santiago

Managing Partner
Steelsky Ventures

Casey Albert Santiago has 20 years of global operating experience building, scaling and investing in women’s health companies. Casey is a Managing Partner at SteelSky Ventures, a female-led venture capital fund investing in early-stage companies that improve access, care, and outcomes in women's health. Prior to joining SteelSky, Casey invested in early-stage digital health & consumer health start-ups in partnership with Johnson & Johnson. She was CEO/Founder of Kangu, a maternal health tech platform that was acquired in 2018, and was an early product leader at Kiva, which has facilitated billions of dollars in microloans to female entrepreneurs in the US and globally. Casey serves as an advisor to a number of venture-backed women’s health start-ups and speaks frequently on entrepreneurship and women’s health. She holds a BA from Wellesley College, an MBA from Columbia Business School.

 

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan is the Chief Executive Officer and a Co-Founder of Granata Bio, a US based biopharma company focused on women’s health and fertility.  In his role, Evan is responsible for Granata Bio’s corporate, customer, and commercial strategies.

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan is the Chief Executive Officer and a Co-Founder of Granata Bio, a US based biopharma company focused on women’s health and fertility.  In his role, Evan is responsible for Granata Bio’s corporate, customer, and commercial strategies.

Before founding Granata Bio, Evan spent nine years at EMD Serono/Merck KgAA.  Most recently, he served as the Marketing and Business Unit Head for the US Fertility/Fertility Technologies businesses.  During this time, Evan spearheaded the creation of innovative programs aimed at expanding access to care for under-recognized patient groups. He has previously served on the corporate council of RESOLVE: The National Infertility Association and the American Society of Reproductive Medicine.

Evan is a graduate of Brown University and received an MBA in Healthcare Leadership from Yale University. He lives in the Boston area with his wife and daughter.

 

Maya Hardigan

Founder & CEO
Mae

Maya Hardigan

Founder & CEO
Mae

Maya Hardigan

Founder & CEO
Mae
 

Michelle Perugini

Co-Founder & CEO
Presagen

Michelle Perugini

Co-Founder & CEO
Presagen

Michelle Perugini

Co-Founder & CEO
Presagen
 

Daniella Gilboa

Co-Founder & CEO
AIVF

Daniella Gilboa

Co-Founder & CEO
AIVF

Daniella Gilboa

Co-Founder & CEO
AIVF
 

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative
 

Brian Levine

M.D., founder and CEO
Nodal

Brian Levine

M.D., founder and CEO
Nodal

Brian Levine

M.D., founder and CEO
Nodal
 

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson

Ru-fong Joanne Cheng

Senior Medical Director, Women's Health, Office of the Chief Medical Officer
Johnson & Johnson
 

Stasia Obremskey

Managing Director
Rhia Ventures

Stasia Obremskey is the Managing Director of RH Capital Funds an impact venture capital fund of Rhia Ventures where she is responsible for investing in innovations in women’s reproductive health.  She joined Rhia Ventures at its founding in 2018 after more than twenty-five years of experience as an interim CFO for non-profit organizations and start-up companies and an impact investor and philanthropist in women’s reproductive health.  She holds a bachelor’s degree in Business Administration with a concentration in Finance from the University of Notre Dame and an MBA from the Harvard Graduat

Stasia Obremskey

Managing Director
Rhia Ventures

Stasia Obremskey

Managing Director
Rhia Ventures

Stasia Obremskey is the Managing Director of RH Capital Funds an impact venture capital fund of Rhia Ventures where she is responsible for investing in innovations in women’s reproductive health.  She joined Rhia Ventures at its founding in 2018 after more than twenty-five years of experience as an interim CFO for non-profit organizations and start-up companies and an impact investor and philanthropist in women’s reproductive health.  She holds a bachelor’s degree in Business Administration with a concentration in Finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. She has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions.  Stasia is a founding member of The Maverick Collective, an initiative of PSI.  As the proud mother of three young adults, she is working with scientists and entrepreneurs to find the next generation of hormone-free contraceptives to meet their sexual health needs.

 

Angeline N. Beltsos

MD, Reproductive Endocrinologist & CEO, Clinical
Kindbody

Angeline N. Beltsos

MD, Reproductive Endocrinologist & CEO, Clinical
Kindbody

Angeline N. Beltsos

MD, Reproductive Endocrinologist & CEO, Clinical
Kindbody
 

Noelle Acosta

Founder & CEO
Noula Health

Noelle Acosta is the Co-Founder & CEO of Noula Health, a digital health company that provides personalized reproductive health care for women and birthing people via at-home precision health testing and 1-on-1 virtual support from experts. Noelle is one of less than 100 Latina female founders to have ever raised over $1M for her startup. Prior to Noula, Noelle has helped lead and scale sales and business development teams at startups in the Bay Area and New York City. Noelle is also a certified birth doula and passionate about accessible, equitable healthcare for all. 

Noelle Acosta

Founder & CEO
Noula Health

Noelle Acosta

Founder & CEO
Noula Health

Noelle Acosta is the Co-Founder & CEO of Noula Health, a digital health company that provides personalized reproductive health care for women and birthing people via at-home precision health testing and 1-on-1 virtual support from experts. Noelle is one of less than 100 Latina female founders to have ever raised over $1M for her startup. Prior to Noula, Noelle has helped lead and scale sales and business development teams at startups in the Bay Area and New York City. Noelle is also a certified birth doula and passionate about accessible, equitable healthcare for all. 

 

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice

Jackie Rotman

Founder
Center of Intimacy Justice
 

Danika Severino Wynn

VP of Abortion Access
Planned Parenthood

Danika Severino Wynn

VP of Abortion Access
Planned Parenthood

Danika Severino Wynn

VP of Abortion Access
Planned Parenthood
 

Arielle Bogorad

SVP of Employer Market Strategy
Progyny

Arielle Bogorad

SVP of Employer Market Strategy
Progyny

Arielle Bogorad

SVP of Employer Market Strategy
Progyny
 

Asima Ahmad

Co-Founder and Chief Medical Officer
Carrot

Asima Ahmad

Co-Founder and Chief Medical Officer
Carrot

Asima Ahmad

Co-Founder and Chief Medical Officer
Carrot
 

Beth Zoneraich

Chief Operating Officer
Pinnacle Fertility

Beth Zoneraich

Chief Operating Officer
Pinnacle Fertility

Beth Zoneraich

Chief Operating Officer
Pinnacle Fertility
 

Anate Brauer

Dr, MD, IVF Director
Shady Grove Fertility - New York

Anate Brauer

Dr, MD, IVF Director
Shady Grove Fertility - New York

Anate Brauer

Dr, MD, IVF Director
Shady Grove Fertility - New York
 

Serena H Chen

MD, Director, Reproductive Medicine
IRMS Institute for Reproductive Medicine / Doctors for Fertility

Serena H Chen

MD, Director, Reproductive Medicine
IRMS Institute for Reproductive Medicine / Doctors for Fertility

Serena H Chen

MD, Director, Reproductive Medicine
IRMS Institute for Reproductive Medicine / Doctors for Fertility
 

Khaled Kteily

Founder & CEO
Legacy

Khaled Kteily

Founder & CEO
Legacy

Khaled Kteily

Founder & CEO
Legacy
 

Sabrina Martucci Johnson

Founder and CEO
DARÉ Bioscience

Sabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.   

 

Sabrina Martucci Johnson

Founder and CEO
DARÉ Bioscience

Sabrina Martucci Johnson

Founder and CEO
DARÉ Bioscience

Sabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.   

 

Sabrina is committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women.  Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.  

 

Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.  

 

Sabrina currently serves on the boards of ATAI Life Sciences, a publicly-traded clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer, BIOCOM, as Vice President of Industry, the Clearity Foundation as Chair, and the YWCA of San Diego County as Past President. Additionally, Sabrina serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International. 

Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, with the Individual in Life Science award in 2017 and the same year received the “Moxie” for her grit and determination and positive impact in the community from the award-winning MOXIE Theatre, a Southern California theatre dedicated to producing diverse and honest images of women using the art of theatre.  She was an E&Y Entrepreneur of the Year San Diego finalist in 2018 and in 2019 was recognized as an entrepreneur in the PharmaVoice 100 and honored as 2019 Director of the Year in the Emerging Board Leader category by the San Diego Corporate Directors Forum. 

 

Kristin Brogaard

PhD, Co-Founder and CSO
Inherent Biosciences

Kristin Brogaard

PhD, Co-Founder and CSO
Inherent Biosciences

Kristin Brogaard

PhD, Co-Founder and CSO
Inherent Biosciences
 

Lauren Berson Sugarman

CEO & Founder
Conceive

Lauren Berson Sugarman

CEO & Founder
Conceive

Lauren Berson Sugarman

CEO & Founder
Conceive
 

Pam Pure

CEO
Posterity Health

Pam Pure, CEO and Co-Founder of Posterity Health, is on a mission to give every couple who is trying to conceive access to inclusive male fertility care. She is an experienced digital healthcare executive and inspirational leader who has built, run and scaled market leading healthcare companies. She served as the CEO of HealthMEDX, EVP of McKesson Technologies and has extensive board experience with small venture backed start-up companies, including NurseGrid and Bivarus, and large public and private companies including MModal and ChangeHealthcare.

Pam Pure

CEO
Posterity Health

Pam Pure

CEO
Posterity Health

Pam Pure, CEO and Co-Founder of Posterity Health, is on a mission to give every couple who is trying to conceive access to inclusive male fertility care. She is an experienced digital healthcare executive and inspirational leader who has built, run and scaled market leading healthcare companies. She served as the CEO of HealthMEDX, EVP of McKesson Technologies and has extensive board experience with small venture backed start-up companies, including NurseGrid and Bivarus, and large public and private companies including MModal and ChangeHealthcare.

 

Abigail Sirus

AWM Investments, Inc

Abigail Sirus is a member of the life sciences investment team at AWM Investments, Inc. which evaluates investments in reproductive medicine venture capital and life sciences public equities.

Abigail Sirus

AWM Investments, Inc

Abigail Sirus

AWM Investments, Inc

Abigail Sirus is a member of the life sciences investment team at AWM Investments, Inc. which evaluates investments in reproductive medicine venture capital and life sciences public equities.

After graduating from Boston College, Abigail joined IBM as a technology consultant focused on blockchain implementations for healthcare and life sciences clients. Abigail was IBM lead for the FDA DSCSA Blockchain Interoperability Pilot collaboration with KPMG, Merck, and Walmart, and for the New York State Excelsior Pass Project (COVID-19 HealthPass) which used blockchain for digital identity validation, then joined. IBM’s Alternative Monetization team which monetizes IP assets across IBM's business units and was part of a core team that provided strategy and M&A activities for emerging technologies like blockchain and quantum computing.

 

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy
 

Roopan Gill

MD MPH FRCSC (ObGyn),Co-Founder & Executive Director
Vitala Global Foundation

Roopan is co-founder and executive director of Vitala Global Foundation - a Canadian not-for-profit that commits to developing digital solutions that support and facilitate access to safe abortion care in challenging contexts globally. She is an obstetrician gynecologist and provides abortion care in Toronto. She works with Medecins Sans Frontieres as an emergency OBGYN and previously with the World Health Organization (WHO). Most recently, she was featured in Forbes as 1 of 7 female leaders committed to inclusivity and accessibility.

Roopan Gill

MD MPH FRCSC (ObGyn),Co-Founder & Executive Director
Vitala Global Foundation

Roopan Gill

MD MPH FRCSC (ObGyn),Co-Founder & Executive Director
Vitala Global Foundation

Roopan is co-founder and executive director of Vitala Global Foundation - a Canadian not-for-profit that commits to developing digital solutions that support and facilitate access to safe abortion care in challenging contexts globally. She is an obstetrician gynecologist and provides abortion care in Toronto. She works with Medecins Sans Frontieres as an emergency OBGYN and previously with the World Health Organization (WHO). Most recently, she was featured in Forbes as 1 of 7 female leaders committed to inclusivity and accessibility.

 

Traci Baird

President & CEO
Engender Health

Traci L. Baird is President & CEO of EngenderHealth, a global organization committed to advancing sexual and reproductive health and rights and gender equality. Traci has worked across Africa, Asia, Eastern Europe, and in the Americas on topics related to women’s health. Prior to leading EngenderHealth Traci was CEO of SHIFT NC, a non-profit adolescent and young adult sexual health organization working across North Carolina. Traci started her global health career at Ipas, where she worked for more than 20 years including as Executive Vice President of Programs.

Traci Baird

President & CEO
Engender Health

Traci Baird

President & CEO
Engender Health

Traci L. Baird is President & CEO of EngenderHealth, a global organization committed to advancing sexual and reproductive health and rights and gender equality. Traci has worked across Africa, Asia, Eastern Europe, and in the Americas on topics related to women’s health. Prior to leading EngenderHealth Traci was CEO of SHIFT NC, a non-profit adolescent and young adult sexual health organization working across North Carolina. Traci started her global health career at Ipas, where she worked for more than 20 years including as Executive Vice President of Programs. Traci earned a master of public health degree from the University of North Carolina at Chapel Hill and a bachelor of arts degree in human biology with a concentration in women’s health from Stanford University.

 

Carlos Guerrero

Ph.D., HCLD, ELD, CC, Scientific Director
Fertility Specialists of Texas

Carlos Guerrero

Ph.D., HCLD, ELD, CC, Scientific Director
Fertility Specialists of Texas

Carlos Guerrero

Ph.D., HCLD, ELD, CC, Scientific Director
Fertility Specialists of Texas
 

Dana Northcraft

Founding Director
RHITES (Reproductive Health Initiative for Telehealth Equity & Solutions)

Dana Northcraft

Founding Director
RHITES (Reproductive Health Initiative for Telehealth Equity & Solutions)

Dana Northcraft

Founding Director
RHITES (Reproductive Health Initiative for Telehealth Equity & Solutions)
 

Jannine Versi

COO & Co-Founder
Elektra Health

Jannine Versi

COO & Co-Founder
Elektra Health

Jannine Versi

COO & Co-Founder
Elektra Health
 

Megan Murphy

Associate Director of Events and Engagement
PCOS Challenge

Meg Murphy is the Associate Director of Events and Engagement at PCOS Challenge: The National Polycystic Ovary Syndrome Association. Serving 57,000 members, PCOS Challenge is the leading nonprofit support organization globally that is advancing the cause for people affected by PCOS. PCOS Challenge hosts the largest and most influential PCOS educational events in the nation, which serve both patients and healthcare providers. They are the leading organization advocating for and shaping public policy with regard to women and girls impacted by polycystic ovary syndrome.

Megan Murphy

Associate Director of Events and Engagement
PCOS Challenge

Megan Murphy

Associate Director of Events and Engagement
PCOS Challenge

Meg Murphy is the Associate Director of Events and Engagement at PCOS Challenge: The National Polycystic Ovary Syndrome Association. Serving 57,000 members, PCOS Challenge is the leading nonprofit support organization globally that is advancing the cause for people affected by PCOS. PCOS Challenge hosts the largest and most influential PCOS educational events in the nation, which serve both patients and healthcare providers. They are the leading organization advocating for and shaping public policy with regard to women and girls impacted by polycystic ovary syndrome.


Meg attended her first PCOS Challenge symposium in 2014 and learned more in that one afternoon than she had in years as a patient. She immediately signed on as a volunteer and went on to become a Patient Advisory Board member. In January 2022, Meg joined the PCOS Challenge team full-time. Meg is passionate about empowering other people with PCOS to advocate for their health.


Prior to joining PCOS Challenge, Meg worked in the Office of Research Affairs at UC San Diego. She is a runner and recently launched the PCOS Challenge Race Team at the Los Angeles Marathon. Meg received her B.A. from Boston University and resides in San Diego, California with her husband.

 

 

Kevin Eisenfrats

Co-Founder & CEO
Contraline

Kevin Eisenfrats

Co-Founder & CEO
Contraline

Kevin Eisenfrats

Co-Founder & CEO
Contraline
 

Vidhi Data

Co-Founder
She Raises Capital

Vidhi Data

Co-Founder
She Raises Capital

Vidhi Data

Co-Founder
She Raises Capital
 

Dhammika Perera

MBBS, MPH, FFPH, PhD, Global Medical Director
MSI Reproductive Choices

Dhammika Perera

MBBS, MPH, FFPH, PhD, Global Medical Director
MSI Reproductive Choices

Dhammika Perera

MBBS, MPH, FFPH, PhD, Global Medical Director
MSI Reproductive Choices
 

Kate Devine

MD, FACOG, Executive Medical Director and Chief Research Officer
USFertility

Kate Devine

MD, FACOG, Executive Medical Director and Chief Research Officer
USFertility

Kate Devine

MD, FACOG, Executive Medical Director and Chief Research Officer
USFertility
 

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics
 

Carmen Messerlian

PhD Assistant Professor of Reproductive Epidemiology
Harvard Chan School of Public Health and Massachusetts General Hospital Fertility Center

Carmen Messerlian

PhD Assistant Professor of Reproductive Epidemiology
Harvard Chan School of Public Health and Massachusetts General Hospital Fertility Center

Carmen Messerlian

PhD Assistant Professor of Reproductive Epidemiology
Harvard Chan School of Public Health and Massachusetts General Hospital Fertility Center
 

Gary L. Harton

PhD, Chief Scientifc Officer
BioSkryb Genomics

Gary L. Harton

PhD, Chief Scientifc Officer
BioSkryb Genomics

Gary L. Harton

PhD, Chief Scientifc Officer
BioSkryb Genomics
 

Ryan Morin

Director of Total Rewards
Boston Beer Company

Ryan Morin

Director of Total Rewards
Boston Beer Company

Ryan Morin

Director of Total Rewards
Boston Beer Company
 

Kylie Long

Venture Partner
Coyote Ventures

Kylie Long

Venture Partner
Coyote Ventures

Kylie Long

Venture Partner
Coyote Ventures

AUDIENCE BREAKDOWN

Start Ups

We are committed to increasing exposure of emerging companies in reproductive health, at all stages of growth and development who are seeking partnership opportunities and are at the forefront of shaping the
future of this space.

Big Pharma/Medical Device/Biotech

At the forefront of women’s health innovation, Big Pharma, Medical Device, and Biotech companies play a key role in shaping the investments and innovation happening in the reproductive health sphere.

 

Investor, Funding Groups

We look to bring together leading investors with a particular focus in reproductive health, ranging from seed, to angel, venture capital firms, private equity, funds, and advisors.

Payers, Providers, Employers

Payors, insurance companies, and benefit providers provide an important bridge between stakeholders within the reproductive health industry, and we are delighted to have more joining us at this years’ summit.

Service Providers

Industry support and service providers include advocacy groups, researchers, knowledge leaders and accelerators such as consultants, lawyers, CROs, non-profits and regulatory experts

FMCGs

Fast moving consumer goods companies play an important role in the reproductive health landscape, and the women’s health landscape more broadly, and include companies such as Johnson & Johnson and Holland & Barrett.

2023 Partners

Headline Partner

Innovation Partner

Gold Partners

Event Partners

Media Partners

Partnering Opportunities for 2023

The Reproductive Health Innovation Summit is an opportunity to strengthen and elevate your position in a growing market, which is ripe for partnerships and investment.

Based on your objective, we can create bespoke packages tailored specifically to you. From presenting your expertise, hosting a panel discussion, virtual networking booths, exclusive pitching sessions or webinars. We’re dedicated to helping you showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories:

THOUGHT LEADERSHIP                                   BRANDING                                   NETWORKING

For any Partnering Opportunities enquiries, please contact Sam Grimsley.

       +44 (0)20 3897 9536           [email protected]

Register

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

TICKET PRICES INCREASE IN

Thursday, August 4, 2022 to Thursday, February 16, 2023
Academic/NPO/Charity Rate
$699
Academic
Not-for-profit Organisations
Charities
Advocacy Groups
Government Bodies
Health Care Professionals
Saturday, November 19, 2022 to Friday, January 6, 2023
Emerging - Under 5mil Rev
$899
Early Bird (Register before 6th January and save $100)
Start-Up/Emerging Organisations
FemTech
MenoTech
Accelerators
Saturday, November 19, 2022 to Thursday, January 26, 2023
Emerging - Under 10mil Rev
$1,099
Early Bird (Register before 6th January and save $100)
Start-Up/Emerging Organisations
FemTech
MenoTech
Accelerators
Saturday, November 19, 2022 to Thursday, January 26, 2023
Industry
$1,899
Early Bird (Register before 6th January and save $200)
Pharmaceutical
Medical Device
Biotechnology
Investors
Payors/Insurance
Employers
Saturday, November 19, 2022 to Thursday, January 26, 2023
Service Providers
$2,699
Early Bird (Register before 6th January and save $200)
Consultancies
Financial Advisors
Lawyers
CRO’s
Laboratories
Preparing registration...

Download our 2023 Agenda

View our 2023 Reproductive Health Innovation Summit agenda!

Sessions include:

  • Implications of Roe vs Wade; Navigating the 2022 Repercussions

  • The Journey to Health Equity through Increasing Access to Care

  • The Unknown Factor within Clinical Trials: The FDA’s PRGLAC Report
  • Private Equity x Fertility Clinics: Challenges vs Opportunities

Our agenda provides all the information you need to book your place at Reproductive Health Innovation Summit USA, access your copy today!

Download the Reproductive Health Innovation Summit Agenda

Venue

50 Park Plaza, Boston, MA 02116, United States

Boston Park Plaza is situated in the Theatre District in Boston, 150 yards from Boston Public Garden, 400 yards from Boston Common and 500 yards from John Hancock Tower. Guests can enjoy the on-site restaurant.

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Women's Health Innovation Series: Women's Healthy Aging Summit

Women's Health Innovation Summit, Europe

Women's Health Innovation Summit 2023